外显子-话题@MedSci

#外显子#

85篇内容 | 2098人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1619091, encodeId=c5a61619091d0, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=Neurology：北京天坛医院神经外科团队新成果——脑动静脉畸形患者De Novo和罕见基因变异的外显子全序列分析, objectType=article, longId=725535, objectId=fb6be2553530, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb6be2553530, replyNumber=0, likeNumber=66, createdTime=2022-04-28, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6be2553530, moduleTitle=Neurology：北京天坛医院神经外科团队新成果——脑动静脉畸形患者De Novo和罕见基因变异的外显子全序列分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6be2553530)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619090, encodeId=2d8a1619090f9, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=AACR重磅之GLORY试验：SCC244对携带MET 14外显子跳变（METex14）的NSCLC患者的II期研究, objectType=article, longId=723990, objectId=9450e23990da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9450e23990da, replyNumber=0, likeNumber=47, createdTime=2022-04-12, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9450e23990da, moduleTitle=AACR重磅之GLORY试验：SCC244对携带MET 14外显子跳变（METex14）的NSCLC患者的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9450e23990da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619089, encodeId=2dac161908946, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=Neurology：通过单例全外显子组和全基因组测序有效诊断遗传性脑白质疾病, objectType=article, longId=299242, objectId=7f60299242f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f60299242f2, replyNumber=0, likeNumber=80, createdTime=2022-02-21, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f60299242f2, moduleTitle=Neurology：通过单例全外显子组和全基因组测序有效诊断遗传性脑白质疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f60299242f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619088, encodeId=ce5c161908853, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=Front Oncol：真实世界数据探索EGFR 18外显子突变NSCLC患者的治疗策略和预后, objectType=article, longId=294587, objectId=24a229458ebf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24a229458ebf, replyNumber=0, likeNumber=68, createdTime=2022-01-25, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24a229458ebf, moduleTitle=Front Oncol：真实世界数据探索EGFR 18外显子突变NSCLC患者的治疗策略和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24a229458ebf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619087, encodeId=268e161908ecd, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=BMC Cancer：EGFR 19外显子缺失插入突变患者一代EGFR-TKI治疗应答较好，获得T790M突变后奥希替尼治疗同样应答较好, objectType=article, longId=292019, objectId=0498292019ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0498292019ed, replyNumber=0, likeNumber=100, createdTime=2021-12-18, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0498292019ed, moduleTitle=BMC Cancer：EGFR 19外显子缺失插入突变患者一代EGFR-TKI治疗应答较好，获得T790M突变后奥希替尼治疗同样应答较好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0498292019ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619086, encodeId=ba8116190867c, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=Clin Cancer Res：Tepotinib治疗MET外显子14 (METex14)跳跃NSCLC患者的疗效和安全性：VISION研究, objectType=article, longId=220835, objectId=9070220835a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9070220835a6, replyNumber=0, likeNumber=65, createdTime=2021-11-24, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9070220835a6, moduleTitle=Clin Cancer Res：Tepotinib治疗MET外显子14 (METex14)跳跃NSCLC患者的疗效和安全性：VISION研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9070220835a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619085, encodeId=754316190854e, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=Clin Cancer Res: KIT外显子9突变的GIST患者接受辅助伊马替尼治疗的疗效：欧洲多中心回顾性研究, objectType=article, longId=218389, objectId=dae121838997, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dae121838997, replyNumber=0, likeNumber=86, createdTime=2021-10-12, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dae121838997, moduleTitle=Clin Cancer Res: KIT外显子9突变的GIST患者接受辅助伊马替尼治疗的疗效：欧洲多中心回顾性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dae121838997)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619084, encodeId=efa616190846b, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=J Clin Oncol：波齐替尼(Poziotinib)治疗HER2外显子20突变的晚期NSCLC的疗效和安全性, objectType=article, longId=217605, objectId=134f21e60540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=134f21e60540, replyNumber=0, likeNumber=110, createdTime=2021-09-26, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=134f21e60540, moduleTitle=J Clin Oncol：波齐替尼(Poziotinib)治疗HER2外显子20突变的晚期NSCLC的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=134f21e60540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619083, encodeId=abe0161908340, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物, objectType=article, longId=217428, objectId=aa6621e428d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa6621e428d6, replyNumber=0, likeNumber=82, createdTime=2021-09-24, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa6621e428d6, moduleTitle=武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa6621e428d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619082, encodeId=c0081619082af, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=J Clin Oncol: Amivantamab治疗铂类进展的EGFR 20外显子插入突变非小细胞肺癌的安全性和疗效：I期研究CHRYSALIS的初次分析结果, objectType=article, longId=215256, objectId=71942152560f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71942152560f, replyNumber=0, likeNumber=71, createdTime=2021-08-05, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71942152560f, moduleTitle=J Clin Oncol: Amivantamab治疗铂类进展的EGFR 20外显子插入突变非小细胞肺癌的安全性和疗效：I期研究CHRYSALIS的初次分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71942152560f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619081, encodeId=03b016190818d, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=JNNP：提高护理转诊中心外显子组测序的效率：罕见神经遗传疾病的新突变、临床表现和诊断挑战, objectType=article, longId=212998, objectId=5242212998c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5242212998c0, replyNumber=0, likeNumber=72, createdTime=2021-06-22, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5242212998c0, moduleTitle=JNNP：提高护理转诊中心外显子组测序的效率：罕见神经遗传疾病的新突变、临床表现和诊断挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5242212998c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619080, encodeId=84b61619080ef, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=武田呈报mobocertinib的全新结果，进一步证实EGFR外显子20插入+ mNSCLC患者的临床收益, objectType=article, longId=211619, objectId=39722116191a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39722116191a, replyNumber=0, likeNumber=104, createdTime=2021-05-23, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39722116191a, moduleTitle=武田呈报mobocertinib的全新结果，进一步证实EGFR外显子20插入+ mNSCLC患者的临床收益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39722116191a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619079, encodeId=5b6516190e98d, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=武田宣布美国FDA将优先审理Mobocertinib (TAK-788)治疗EGFR外显子20插入+转移性非小细胞肺癌的新药报批, objectType=article, longId=210637, objectId=db3b21063ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db3b21063ea2, replyNumber=0, likeNumber=64, createdTime=2021-05-01, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db3b21063ea2, moduleTitle=武田宣布美国FDA将优先审理Mobocertinib (TAK-788)治疗EGFR外显子20插入+转移性非小细胞肺癌的新药报批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db3b21063ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619078, encodeId=15f916190e84c, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=JAMA：外显子测序显示脑瘫患儿中，超过三成是由于致病突变导致的, objectType=article, longId=206741, objectId=8403206e4127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8403206e4127, replyNumber=0, likeNumber=84, createdTime=2021-02-05, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8403206e4127, moduleTitle=JAMA：外显子测序显示脑瘫患儿中，超过三成是由于致病突变导致的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8403206e4127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619077, encodeId=1d3e16190e72f, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=武田呈报Mobocertinib治疗先前接受过含铂化疗的EGFR外显子20插入+ mNSCLC患者的阳性结果, objectType=article, longId=206667, objectId=b05220666ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b05220666ed0, replyNumber=0, likeNumber=81, createdTime=2021-02-04, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b05220666ed0, moduleTitle=武田呈报Mobocertinib治疗先前接受过含铂化疗的EGFR外显子20插入+ mNSCLC患者的阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b05220666ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619076, encodeId=bf3d16190e6c5, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=WCLC 2020：Neratinib治疗EGFR外显子18突变的转移性非小细胞肺癌，II期研究取得相对积极的结果, objectType=article, longId=206509, objectId=3eca206509d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eca206509d2, replyNumber=0, likeNumber=56, createdTime=2021-02-02, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eca206509d2, moduleTitle=WCLC 2020：Neratinib治疗EGFR外显子18突变的转移性非小细胞肺癌，II期研究取得相对积极的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eca206509d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619075, encodeId=3efe16190e56d, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=Lancet Neurology：肌张力障碍的单基因变异：一项外显子全序列研究, objectType=article, longId=203654, objectId=3aa12036541f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aa12036541f, replyNumber=0, likeNumber=60, createdTime=2020-11-24, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aa12036541f, moduleTitle=Lancet Neurology：肌张力障碍的单基因变异：一项外显子全序列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aa12036541f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619074, encodeId=9dbc16190e47c, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=NEJM：外显子组测序用于非免疫性胎儿水肿的产前诊断, objectType=article, longId=201938, objectId=f45c20193864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f45c20193864, replyNumber=0, likeNumber=76, createdTime=2020-10-12, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f45c20193864, moduleTitle=NEJM：外显子组测序用于非免疫性胎儿水肿的产前诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f45c20193864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619073, encodeId=a90d16190e3a0, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=NEJM：Tepotinib治疗MET外显子14跳跃突变非小细胞肺癌II期临床效果显著, objectType=article, longId=200217, objectId=5dcd20021e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dcd20021e20, replyNumber=0, likeNumber=63, createdTime=2020-09-05, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dcd20021e20, moduleTitle=NEJM：Tepotinib治疗MET外显子14跳跃突变非小细胞肺癌II期临床效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dcd20021e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1619072, encodeId=2b9016190e25e, content=<a href='/topic/show?id=492a42862bd' target=_blank style='color:#2F92EE;'>#外显子#</a>, objectTitle=Nat Med：外显子测序帮助筛查新生儿先天性代谢错误, objectType=article, longId=199633, objectId=a20f19963397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a20f19963397, replyNumber=0, likeNumber=62, createdTime=2020-08-19, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a20f19963397, moduleTitle=Nat Med：外显子测序帮助筛查新生儿先天性代谢错误, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a20f19963397)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

外显子

2020-05-29

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

Neurology：北京天坛医院神经外科团队新成果——脑动静脉畸形患者De Novo和罕见基因变异的外显子全序列分析

2022-04-28

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

AACR重磅之GLORY试验：SCC244对携带MET 14外显子跳变（METex14）的NSCLC患者的II期研究

2022-04-12

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

Neurology：通过单例全外显子组和全基因组测序有效诊断遗传性脑白质疾病

2022-02-21

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

Front Oncol：真实世界数据探索EGFR 18外显子突变NSCLC患者的治疗策略和预后

2022-01-25

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

BMC Cancer：EGFR 19外显子缺失插入突变患者一代EGFR-TKI治疗应答较好，获得T790M突变后奥希替尼治疗同样应答较好

2021-12-18

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

Clin Cancer Res：Tepotinib治疗MET外显子14 (METex14)跳跃NSCLC患者的疗效和安全性：VISION研究

2021-11-24

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

Clin Cancer Res: KIT外显子9突变的GIST患者接受辅助伊马替尼治疗的疗效：欧洲多中心回顾性研究

2021-10-12

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

J Clin Oncol：波齐替尼(Poziotinib)治疗HER2外显子20突变的晚期NSCLC的疗效和安全性

2021-09-26

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物

2021-09-24

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

J Clin Oncol: Amivantamab治疗铂类进展的EGFR 20外显子插入突变非小细胞肺癌的安全性和疗效：I期研究CHRYSALIS的初次分析结果

2021-08-05

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

JNNP：提高护理转诊中心外显子组测序的效率：罕见神经遗传疾病的新突变、临床表现和诊断挑战

2021-06-22

docwu2019 (审核中...)

前往app查看评论内容

#外显子#

武田呈报mobocertinib的全新结果，进一步证实EGFR外显子20插入+ mNSCLC患者的临床收益

2021-05-23

docwu2019 (审核中...)